The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIPEL.L Regulatory News (IPEL)

  • There is currently no data for IPEL

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

7 Oct 2020 16:15

RNS Number : 4201B
Impellam Group plc
07 October 2020
 

7 October 2020

 

Impellam Group plc

 

("Impellam" or the "Company")

 

Director/PDMR Shareholding

 

 

The Company has been informed that Lord Ashcroft KCMG PC, Chairman of Impellam, today purchased 50,000 ordinary shares of 1 pence each in the capital of the Company ("Ordinary Shares") at a price of 210 pence per Ordinary Share.

 

Enquiries:

Impellam Group plc

Julia Robertson, Chief Executive Officer

 

01582 692 658

Canaccord Genuity Ltd (Nomad and Sole Broker)

Bobbie Hilliam

Georgina McCooke

 

020 7523 8150

 

Note to Editors:

Impellam is the second largest 1  staffing company in the UK and sixth largest 2  Managed Services provider worldwide. Our vision is to be the world's most trusted staffing company - trusted by our people, our customers and our investors in equal measure.

We provide Managed Services and Specialist Staffing solutions across the UK, Europe, US, the Middle East and Australasia. We have over 3,200 Impellam people throughout our network of 17 market-leading brands across 165 worldwide locations.

Ultimately, Impellam Group's mission is to provide fulfilment and a sense of purpose to our people and to help customers build better businesses in a changing world.

For more information about Impellam Group please visit:  www.impellam.com  

1 By revenue (2017 published numbers)

2 By SUM (confirmed by Staffing Industry Analysts. Spend Under Management (SUM) is the total amount of client expenditure which our Managed Services brands manage on behalf of their clients. This equates to revenue earned where Impellam acts as principal plus gross billings to customers where Impellam acts as agent (2017 published numbers). Management use this measure as it reflects the total value of the client spend to the Group and not just the revenue generated

 

Further information is disclosed below in accordance with Article 19 of the Market Abuse Regulation:

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

Michael Anthony Ashcroft

 

 

2

 

Reason for the notification

 

a)

 

Position/status

 

Chairman

 

b)

 

Initial notification /Amendment

 

Initial

 

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

Impellam Group plc

 

b)

 

LEI

 

213800QCQWZBNJ2IUN83

 

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary shares of 1 pence each

 

ISIN: GB00B8HWGJ55

 

b)

 

Nature of the transaction

 

Purchase of Ordinary Shares

 

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

210p

50,000

 

 

 

d)

 

Aggregated information

 

- Aggregated volume

 

- Price

 

N/A - single transaction

 

 

e)

 

Date of the transaction

 

7 October 2020

 

f)

 

Place of the transaction

 

AIMX

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFIEIELDIII
Date   Source Headline
9th Jan 202310:44 amRNSForm 8.5 (EPT/RI)
9th Jan 202310:31 amRNSRule 2.9 Announcement
9th Jan 202310:30 amRNSTransaction in Own Shares
6th Jan 202312:04 pmRNSForm 8.3 - Impellam Group PLC
6th Jan 202310:30 amRNSForm 8.5 (EPT/RI)
5th Jan 20232:33 pmRNSForm 8.3 - Impellam Group PLC
5th Jan 20239:16 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
4th Jan 20231:31 pmRNSForm 8.3 - Impellam Group PLC
4th Jan 20238:22 amRNSForm 8.5 (EPT/RI)
3rd Jan 20237:00 amRNSForm 8.3 - Impellam Group Plc
30th Dec 202210:01 amRNSForm 8.3 - Impellam Group PLC
29th Dec 202211:10 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
29th Dec 20229:53 amRNSForm 8.3 - Impellam Group PLC
28th Dec 202210:51 amRNSForm 8.5 (EPT/RI)
23rd Dec 20229:37 amRNSForm 8.5 (EPT/RI)
22nd Dec 20227:00 amRNSSpecial Dividend Declaration
14th Dec 20222:55 pmRNSRule 2.9 Announcement
14th Dec 20222:30 pmRNSTransaction in Own Shares
14th Dec 20227:28 amRNSForm 8.5 (EPT/RI)
12th Dec 202210:00 amRNSRule 2.9 Announcement
12th Dec 202210:00 amRNSTransaction in Own Shares
12th Dec 20227:48 amRNSForm 8.5 (EPT/RI)
9th Dec 202211:03 amRNSForm 8.5 (EPT/RI)
8th Dec 202211:25 amRNSForm 8.5 (EPT/RI) - Impellam Group plc
6th Dec 20229:51 amRNSForm 8.5 (EPT/RI)
6th Dec 20227:00 amRNSRule 2.9 Announcement
6th Dec 20227:00 amRNSTransaction in Own Shares
2nd Dec 20224:02 pmRNSRule 2.9 Announcement
2nd Dec 20224:01 pmRNSTransaction in Own Shares
2nd Dec 20227:00 amRNSForm 8.5 (EPT/RI)
1st Dec 202212:01 pmRNSRule 2.9 Announcement
1st Dec 202212:00 pmRNSTransaction in Own Shares
1st Dec 202210:02 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:31 amRNSForm 8.5 (EPT/RI)
30th Nov 20227:01 amRNSRule 2.9 Announcement
30th Nov 20227:00 amRNSTransaction in Own Shares
29th Nov 20227:00 amRNSForm 8.5 (EPT/RI)
28th Nov 202211:01 amRNSForm 8.5 (EPT/RI)
28th Nov 20229:00 amRNSRule 2.9 Announcement
28th Nov 20229:00 amRNSTransaction in Own Shares
25th Nov 20229:05 amRNSForm 8.5 (EPT/RI)
23rd Nov 202210:46 amRNSRule 2.9 Announcement
23rd Nov 202210:45 amRNSTransaction in Own Shares
23rd Nov 202210:13 amRNSForm 8.5 (EPT/RI)
22nd Nov 20229:16 amRNSRule 2.9 Announcement
22nd Nov 20229:15 amRNSTransaction in Own Shares
22nd Nov 20228:03 amRNSForm 8.5 (EPT/RI)
21st Nov 202210:45 amRNSForm 8.5 (EPT/RI)
21st Nov 20227:01 amRNSRule 2.9 Announcement
21st Nov 20227:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.